• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1972年至2001年荷兰南部原发性女性乳腺癌后的原发性恶性肿瘤

Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001.

作者信息

Soerjomataram I, Louwman W J, de Vries E, Lemmens V E P P, Klokman W J, Coebergh J W W

机构信息

Netherlands Institute of Health Sciences, Rotterdam, The Netherlands.

出版信息

Breast Cancer Res Treat. 2005 Sep;93(1):91-5. doi: 10.1007/s10549-005-4016-2.

DOI:10.1007/s10549-005-4016-2
PMID:16184464
Abstract

OBJECTIVES

To assess the risk of second primary cancers among women with previous breast cancer and calculate the excess burden of second cancer in the population.

METHODS

A population-based longitudinal study was conducted using the Eindhoven cancer registry data on 9919 breast cancer patients diagnosed in the period 1972-2000 and followed until 2001. Standardised incidence ratios (SIR) and absolute excess risks (AER) were calculated.

RESULTS

In total, 1298 (13%) women developed a second primary cancer. The risk of overall second cancer was higher among breast cancer patients compared to the general population (SIR: 2.8; 95% CI: 2.6-2.9), with an AER of 115 second cancers for every 10,000 breast cancer patients per year. High SIR and AER were observed for breast cancer (SIR: 4.1; 95% CI: 3.8-4.4; AER: 64/10,000 patients/year) and ovarian cancer (SIR: 2.0; 95% CI: 1.5-2.7; AER: 4.5/10,000 patients/year).

CONCLUSIONS

Our recent data show that women with previous breast cancer have an elevated risk of developing a second cancer compared to the general population. Excess burden for the population is especially high for second cancers of the breast, ovary and colon. Screening may only be justified for breast, ovary and colon cancer in certain groups of patients.

摘要

目的

评估既往患乳腺癌女性发生第二原发性癌症的风险,并计算人群中第二癌症的额外负担。

方法

利用埃因霍温癌症登记处的数据进行了一项基于人群的纵向研究,该数据涉及1972年至2000年期间确诊的9919例乳腺癌患者,并随访至2001年。计算标准化发病率(SIR)和绝对超额风险(AER)。

结果

共有1298名(13%)女性发生了第二原发性癌症。与普通人群相比,乳腺癌患者发生总体第二癌症的风险更高(SIR:2.8;95%置信区间:2.6 - 2.9),每年每10000名乳腺癌患者中有115例发生第二癌症的AER。乳腺癌(SIR:4.1;95%置信区间:3.8 - 4.4;AER:64/10000患者/年)和卵巢癌(SIR:2.0;95%置信区间:1.5 - 2.7;AER:4.5/10000患者/年)的SIR和AER较高。

结论

我们的最新数据表明,与普通人群相比,既往患乳腺癌的女性发生第二癌症的风险升高。对于乳腺癌、卵巢癌和结肠癌的第二癌症,人群的额外负担尤其高。在某些患者群体中,仅对乳腺癌、卵巢癌和结肠癌进行筛查可能是合理的。

相似文献

1
Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001.1972年至2001年荷兰南部原发性女性乳腺癌后的原发性恶性肿瘤
Breast Cancer Res Treat. 2005 Sep;93(1):91-5. doi: 10.1007/s10549-005-4016-2.
2
Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001.1972 - 2001年荷兰南部女性乳腺癌后发生第二原发性乳腺癌和泌尿生殖系统癌症的风险
Eur J Cancer. 2005 Oct;41(15):2331-7. doi: 10.1016/j.ejca.2005.01.029. Epub 2005 Sep 1.
3
Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.乳腺癌治疗后发生新发原发性非乳腺癌的风险:一项基于荷兰人群的研究。
J Clin Oncol. 2008 Mar 10;26(8):1239-46. doi: 10.1200/JCO.2007.11.9081.
4
Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.视网膜母细胞瘤幸存者发生二次恶性肿瘤的风险:超过40年的随访
J Natl Cancer Inst. 2008 Dec 17;100(24):1771-9. doi: 10.1093/jnci/djn394. Epub 2008 Dec 9.
5
Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001.1977年至2001年期间,在丹麦乳腺癌合作组(DBCG)77、82和89方案的协议中登记或随机分组的早期可手术乳腺癌患者发生第二原发性癌症的风险。
Acta Oncol. 2008;47(4):755-64. doi: 10.1080/02841860801978921.
6
Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.加拿大不列颠哥伦比亚省儿童和青少年癌症5年幸存者中发生第二种恶性肿瘤的风险。
Pediatr Blood Cancer. 2007 Apr;48(4):453-9. doi: 10.1002/pbc.20921.
7
Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan.年轻女性乳腺癌患者发生第二原发性恶性肿瘤的风险增加:一项基于台湾人群的研究
Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2647-55. doi: 10.1158/1055-9965.EPI-08-0109.
8
Risk of second primary malignancies in women with papillary thyroid cancer.乳头状甲状腺癌女性患者发生第二原发性恶性肿瘤的风险。
Am J Epidemiol. 2006 Mar 15;163(6):521-7. doi: 10.1093/aje/kwj072. Epub 2006 Jan 18.
9
Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.乳腺癌、前列腺癌或结直肠癌诊断后5年内的二次癌症发病率:一项基于人群的研究。
Eur J Cancer Prev. 2009 Sep;18(5):343-8. doi: 10.1097/CEJ.0b013e32832abd76.
10
Second neoplasms after invasive and borderline ovarian cancer.浸润性和交界性卵巢癌后的第二原发性肿瘤
Eur J Cancer Prev. 2009 Jun;18(3):216-9. doi: 10.1097/CEJ.0b013e3283240474.

引用本文的文献

1
Risk of second primary cancer in young breast cancer survivors: an important yet overlooked issue.年轻乳腺癌幸存者发生第二原发性癌症的风险:一个重要却被忽视的问题。
Ther Adv Med Oncol. 2025 Feb 24;17:17588359251321904. doi: 10.1177/17588359251321904. eCollection 2025.
2
Increased risk of subsequent primary lung cancer among female hormone-related cancer patients: A meta-analysis based on over four million cases.女性激素相关癌症患者后续原发性肺癌风险增加:基于超过 400 万例病例的荟萃分析。
Chin Med J (Engl). 2024 Aug 5;137(15):1790-1801. doi: 10.1097/CM9.0000000000003132. Epub 2024 Jul 8.
3
Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary Breast and Colorectal Cancer Patients.
遗传性乳腺癌和结直肠癌患者中种系基因组变异和拷贝数变异的共存。
Genes (Basel). 2023 Aug 3;14(8):1580. doi: 10.3390/genes14081580.
4
Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort.凯泽永久乳腺癌生存者队列中女性的第二原发癌风险。
Breast Cancer Res. 2023 May 3;25(1):50. doi: 10.1186/s13058-023-01647-y.
5
Links between Breast and Thyroid Cancer: Hormones, Genetic Susceptibility and Medical Interventions.乳腺癌与甲状腺癌之间的联系:激素、遗传易感性及医学干预措施
Cancers (Basel). 2022 Oct 19;14(20):5117. doi: 10.3390/cancers14205117.
6
The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.乳腺癌与分化型甲状腺癌的共存:发病率、相关性及其对日常实践的临床意义。
BMC Cancer. 2022 Sep 26;22(1):1018. doi: 10.1186/s12885-022-10069-6.
7
Second primary malignancies in colorectal cancer patients.结直肠癌患者的第二原发恶性肿瘤。
Sci Rep. 2021 Feb 2;11(1):2759. doi: 10.1038/s41598-021-82248-7.
8
Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer.导管原位癌和浸润性乳腺癌患者对侧乳腺癌的风险
NPJ Breast Cancer. 2020 Nov 3;6(1):60. doi: 10.1038/s41523-020-00202-8.
9
Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer.原发性乳腺癌和原发性卵巢癌患者的临床特征及生存结局
Medicine (Baltimore). 2020 Aug 7;99(32):e21560. doi: 10.1097/MD.0000000000021560.
10
Patients with non-colorectal cancers may be at elevated risk of colorectal neoplasia.非结直肠癌患者可能患结直肠肿瘤的风险更高。
J Cancer. 2020 Mar 4;11(11):3192-3198. doi: 10.7150/jca.40724. eCollection 2020.